The implications of microarray technology for animal use in scientific research

Alternatives to Laboratory Animals

Volumn 30, Issue 4, 2002, Pages 459-465

  Jenkins, Elizabeth S ^a   Broadhead, Caren ^a   Combes, Robert D ^a  

^a RUSSELL AND BURCH HOUSE   (United Kingdom)

Author keywords

Alternatives; Animal experiments; DNA arrays; In vitro; In vivo; Microarrays; Reduction; Refinement; Replacement

Indexed keywords

VACCINE;

DNA MICROARRAY; DRUG INDUSTRY; DRUG TARGETING; EXPERIMENTAL ANIMAL WELFARE; GENE EXPRESSION; GENETIC ANALYSIS; IN SITU HYBRIDIZATION; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; REVIEW; TECHNOLOGY; TOXICITY TESTING;

ANIMALIA;

EID: 0036656771     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119290203000408     Document Type: Review

References (42)

1. International Human Genome Sequencing Consortium (2001). Initial sequencing and analysis of the human genome. Nature 409, 860-921.
2. The Sanger Centre (2002). Danio Rerio Sequencing Project. Web site http://www.sanger.ac.uk/Projects/D_rerio/ (Accessed 28.3.02).
3. Mouse Genome Sequencing (MGS) Project (2002). Mouse Genome Informatics. Web site: http://www.informatics.jax.org (Accessed 28.3.02).
4. National Centre for Biotechnology Information. (2002). Expressed Sequence Tags database. Web site http://www.ncbi.nlm.nih.gov/dbEST/dbEST_summary.html (Accessed 28.3.02).
5. Schena, M., Heller, R.A., Theriault, T.P., Konrad, K., Lachenmeier, E. & Davis, R.W. (1998). Microarrays: biotechnologies discovery platform for functional genomics. Trends in Biotechnology 16, 301-306.
6. Debouck, C. & Goodfellow, P.N. (1999). DNA microarrays in drug discovery and development. Nature Genetics 21, 48-50.
7. Nuwaysir, E.F., Bittner, M., Trent, J., Barrett, J.C. & Afshari, C.A. (1999). Microarrays and toxicology: the advent of toxicogenomics. Molecular Carcinogenesis 24, 153-159.
8. Russell, W.M.S. & Burch, R.L. (1959). The Principles of Humane Experimental Technique, 238pp. London, UK: Methuen. Facsimile edition (1992). Potters Bar, Herts, UK: UFAW.
9. Walt, D.R. (2000). Bead-based fiber-optic arrays. Science (New York) 287, 451-452.
10. Bowtell, D.D.L. (1999). Options available - from start to finish - for obtaining expression data by microarray. Nature Genetics 21, 25-32.
11. Duggan, D.J., Bittner, M., Chen, Y., Meltzer, P. & Trent, J.M. (1999). Expression profiling using cDNA microarrays. Nature Genetics 21, 10-14.
12. Khan, J., Saal, L.H., Bittner, M.L., Chen, Y., Trent, J.M. & Meltzer, P.S. (1999). Expression profiling in cancer using cDNA microarrays. Electrophoresis 20, 223-229.
13. Khan, J., Bittner, M.L., Chen, Y., Meltzer, P.S. & Trent, J.M. (1999). DNA microarray technology: the anticipated impact on the study of human disease. Biochimica et Biophysica Acta 1423, M17-M28.
14. National Institute of Environmental Health Sciences (NIEHS) (2002). cDNA Microarrays and the NMC. Web site http://dir.niehs.nih.gov/microarray/backgrnd.htm (Accessed 03.4.02).
15. Lee, C-K., Weindruch, R. & Prolla, T.A. (2000). Gene expression profile of the ageing brain in mice. Nature Genetics 25, 294-297.
16. Okazaki, Y., Miki, R., Mizuno, Y., Tomaru, Y., Kadota, K., Carninci, P., Shibata, K., Itoh, M., Ozawa, Y., Kawai, J., Konno, H., Fukunishi, Y., Kusumi, T., Goto, H., Nitanda, H., Hamaguchi, Y., Nishizuka, I., Muramatsu, M., Yoshiki, J., Kusakabe, M., DeRisi, J., Iyer, V., Eisen, M., Brown, P.O. & Hayashizaki, Y. (1999). Gene expression profiling using a mouse full-length 20 K cDNA microarray. Nature Genetics 23, 66-67.
17. Cirelli, C. & Tononi, G. (1999). Differences in brain gene expression between sleep and waking as revealed by mRNA differential display and cDNA microarray. Journal of Sleep Research 8, Suppl. 1, 44-52.
18. Heller, R.A., Schena, M., Chai, A., Shalon, D., Bedilion, T., Gilmore, J., Woolleys D.E. & Davis, R.W. (1997). Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proceedings of the National Academy of Sciences, USA 94, 2150-2155.
19. DeRisi, J., Penland, L., Brown, P.O., Bittner, M.L., Meltzer, P.S., Ray, M., Chen, Y., Su, Y.A. & Trent, J.M. (1996). Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nature Genetics 14, 457-460.
20. Welford, S.M., Gregg, J., Chen, E., Garrison, D., Sorensen, P.H., Denny, C.T. & Nelson, S.F. (1998). Detection of differentially expressed genes in primary tumor tissues using representational differences analysis coupled to microarray hybridisation. Nucleic Acids Research 26, 3059-3065.
21. Khan, J., Simon, R., Bittner, M., Chen, Y., Leighton, S.B., Pohida, T., Smith, P.D., Jiang, Y., Gooden, G.C., Trent, J.M. & Meltzer, P.S. (1998). Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Research 58, 5009-5013.
22. Moch, H., Schraml, P., Bubendorf, L., Mirlacher, M., Kononen, J., Gasser, T., Mihatsch, M.J., Kallioniemi, O.P. & Sauter, G. (1999). High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. American Journal of Pathology 154, 981-986.
23. Clark, E.A., Golub, T.R., Lander, E.S. & Hynes, R.O. (2000). Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406, 532-535.
24. Whitney, L.W., Becker, K.G., Tresser, N.J., Caballero-Ramos, C.I., Munson, P.J., Prabhu, V.V., Trent, J.M., McFarland, H.F. & Biddison, W.E. (1999). Analysis of gene expression in multiple sclerosis lesions using cDNA microarrays. Annals of Neurology 46, 425-428.
25. Bittner, M., Meltzer, P., Chen, Y., Jiang, Y., Seftor, E., Hendrix, M., Radmacher, M., Simon, R., Yakhini, Z., Ben-dor, A., Sampas, N., Dougherty, E., Wang, E., Marincola, F., Gooden, C., Lueders, J., Glatfelter, A., Pollock, P., Carpten, J., Gillanders, E., Leja, D., Dietrich, K., Beaudry, C., Berens, M., Alberts, D., Sondak, V., Hayward, N. & Trent, J. (2000). Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406, 536-540.
26. Golub, T.R., Slonim, D.K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J.P., Coller, H., Loh, M.L., Downing, J.R., Caligiuri, M.A., Bloomfield, C.D. & Lander, E.S. (1999). Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science (New York) 286, 531-537.
27. Perou, C.M., Sørlie, T., Eisen, M.B., van de Rijn, M., Jeffrey, S.S., Rees, C.A., Pollack, J.R., Ross, D.T., Johnsen, H., Akslen, L.A., Fluge, Ø., Pergamenschikov, A., Williams, C., Zhu, S.X., Lønning, P.E., Børresen-Dale, A-L., Brown, P.O. & Botstein, D. (2000). Molecular portraits of human breast tumours. Nature 406, 747-752.
28. Schuldiner, O. & Benvenisty, N. (2001). A DNA microarray screen for genes involved in c-MYC and n-MYC oncogenesis in human tumours. Oncogene 20, 4984-4994.
29. Yang, J., Fizazi, K., Peleg, S., Sikes, C.R., Raymond, A.K., Jamal, N., Hu, M., Olive, M., Martinez, L.A., Wood, C.G., Logothetis, C.J., Karsenty, G. & Navone, N.M. (2001). Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway. Cancer Research 61, 5652-5659.
30. Atterwill, C.K. & Wing, M.G. (2002). In vitro preclinical lead optimisation technologies (PLOTs) in pharmaceutical development. Toxicology Letters 127, 143-151.
31. Hoffman, E.P. & Dressman, D. (2001). Molecular pathophysiology and targeted therapeutics for muscular dystrophy. Trends in Pharmacological Sciences 22, 465-470.
32. Pennie, W.D., Woodyatt, N.J. Aldridge, T.C. & Orphanides, G. (2001). Application of genomics to the definition of the molecular basis for toxicity. Toxicology Letters 120, 353-358.
33. Farr, S.& Dunn, R.T. (1999). Concise review: gene expression applied to toxicology. Toxicological Sciences 50, 1-9.
34. International Life Sciences Institute (2002). Application of Genomics and Proteomics in Mechanism-based Risk Assessment. http://www.ilsi.org/file/genomics.pdf (Accessed 5.4.02).
35. Waring, J.F., Ciurlionis, R., Jolly, R.A., Heindel, M. & Ulrich, R.G. (2001). Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. Toxicology Letters 120, 359-368.
36. National Institute of Environmental Health Sciences (2000). Press release 29 February 2000: Environmental Health Institute to Use Gene Chips to Evaluate Chemicals for Potential Harm to Humans. Web site http://www.niehs.nih.gov/oc/news/toxchip.htm (Accessed 9.4.02).
37. Afshari, C.A., Nuwaysir, E.F. & Barrett, J.C. (1999). Application of complementary DNA microarray technology to carcinogen identification, toxicology, and drug safety evaluation. Cancer Research 59, 4759-4760.
38. Richmond, J. (1999). Criteria for humane endpoints. In Humane Endpoints in Animal Experiments for Biomedical Research - Proceedings of the International Conference, 22-25 November 1998 Zeist, The Netherlands (ed. C.F.M. Hendriksen & D.B. Morton), pp. 26-32. London, UK: Royal Society of Medicine Press.
39. Fry, J. & George, E. (2001). In vitro toxicology in the light of new technologies. ATLA 29, 745-748.
40. Balls, M. (2001). Animal procedures remain vital to biomedical research: It ain't necessarily so... ATLA 29, 385-388.
41. Pennie, W.D. & Kimber, I. (2002). Toxicogenomics: transcript profiling and potential application to chemical allergy. Toxicology Letters 127, 319-326.
42. Wolf, C.R. (2002). Application of biochemical and genetic approaches to understanding pathways of chemical toxicity. Toxicology Letters 127, 3-17.